Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies.

导出 OA

翻译打印收藏纠错

作者： Neşe,Çakmak-Görür ^[1] ; Josefine,Radke ^[2] ; Simone,Rhein ^[3] ; Elisa,Schumann ^[4] ; Gerald,Willimsky ^[5] ; Frank L,Heppner ^[6] ; Thomas,Blankenstein ^[7] ; Antonio,Pezzutto ^[4]

作者单位： Max Delbrück Center for Molecular Medicine in Helmholtz Association, Berlin, Germany. nese.cakmak@mdc-berlin.de. ^[1] Charité-Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. nese.cakmak@mdc-berlin.de. ^[2] Berlin Institute of Health (BIH), Berlin, Germany. nese.cakmak@mdc-berlin.de. ^[3] Berlin Institute of Health (BIH), Berlin, Germany. ^[4] Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. ^[5] German Cancer Consortium (DKTK), Heidelberg, Germany, Partner Site Berlin, Berlin, Germany. ^[6] Charité-Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. ^[7] Institute of Immunology, Charité-Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. ^[8] German Cancer Research Center (DKFZ), Heidelberg, Germany. ^[9] German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany. ^[10] Max Delbrück Center for Molecular Medicine in Helmholtz Association, Berlin, Germany. ^[11]